$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
全可利使用说明
2025-10-19 11:44:20
Check Details
全可利是一种什么药物呢
2025-10-19 11:44:20
Check Details
全可利适应症有哪些
2025-10-19 11:44:20
Check Details
安立生坦吃多久见效?
2025-10-19 11:44:20
Check Details
安立生坦一个疗程是几天?
2025-10-19 11:44:20
Check Details
安立生坦用了能停吗?
2025-10-19 11:44:20
Check Details
安立生坦什么时候服用效果好?
2025-10-19 11:44:20
Check Details
安立生坦怎么买?
2025-10-19 11:44:20
Check Details
安立生坦一盒多少钱?
2025-10-19 11:44:20
Check Details
安立生坦中文说明书
2025-10-19 11:44:20
Check Details
安立生坦哪里能买到?
2025-10-19 11:44:20
Check Details
安立生坦的效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
3133
3134
3135
3136
3137
3138
3139
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Key points for drug monitoring of Molotinib in bone marrow fibrosis
2
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
3
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
4
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
5
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
6
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
7
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
8
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
9
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
10
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
11
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
12
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL